SCHEMBL16636887

SCHEMBL16636887

Cc1nn(-c2nccs2)cc1-c1ccc(NC(=O)c2ccc(F)c(F)c2F)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 2/20 0.37
GAA P10253 2/20 0.37
TP53 P04637 1/20 0.37
GLA P06280 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 3/20 0.35
MAPT P10636 3/20 0.35
KMT2A Q03164 3/20 0.35
HPGD P15428 1/20 0.35
KCNH2 Q12809 1/20 0.35
PKM P14618 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GRM5 P41594 4/20 0.35
ABCB1 P08183 1/20 0.35
GRIN2B Q13224 3/20 0.35
NR3C1 P04150 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16636510 0.90 IL2 (0.37) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL16636612 0.88 IL2 (0.36) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL16636428 0.85 IL2 (0.45) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL16636863 0.84 IL2 (0.39) NPC1RAB9AKDM4EPKMGRM5
SCHEMBL16637371 0.83 IL2 (0.43) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL16636948 0.83 ABCB1 (0.39) NPC1RAB9AKDM4EPKMGRM5
SCHEMBL16637129 0.82 NR3C1 (0.36) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL16636723 0.81 NPC1 (0.39) NPC1RAB9AALDH1A1SMN1; SMN2KDM4E
SCHEMBL16636680 0.79 IL2 (0.39) MEN1KMT2ANR3C1HTT
SCHEMBL16636932 0.79 SCN9A (0.36) NPC1RAB9AALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9611263-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2017-04-04 US disclosed
US-20160229845-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM AVENUE CAPITAL MANAGEMENT II, L.P. 2016-08-11 US disclosed
WO-2015054283-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2015-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160229845-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NPC1 262/4885RAB9A 1174/4885ALDH1A1 4409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.